Epcoritamab,rituximab,cyclophosphamide,doxorubicin,vincristine,prednisone,lenalidomide,bendamustine,cytarabine,dexamethasone,oxaliplatin,carboplatin,gemcitabine,ifosfamide
Genmab,Abbvie
['lymphoma', 'lenalidomide', 'follicular', 'ritux', 'lymsm', 'epcoritamab', 'rituximab']
epcoritamab plus rituximab/lenalidomide produces responses in high-risk r/r follicular lymphoma #asco23 #lymsm #oncology 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.